middle.news
Entropy Neurodynamics Secures GMP Manufacturing for TRP-8803 Psilocin Therapy
8:20am on Wednesday 19th of August, 2026 AEST
•
Biotechnology
Read Story
Entropy Neurodynamics Secures GMP Manufacturing for TRP-8803 Psilocin Therapy
8:20am on Wednesday 19th of August, 2026 AEST
Key Points
Development and Manufacturing Services Agreement with BioCina
GMP manufacture of proprietary IV-infused psilocin TRP-8803
Manufacturing to support late-stage clinical trials and regulatory submissions
BioCina’s Perth facility to produce sterile vials using robotic aseptic filling
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE